石药集团(01093)：石药创新(300765.SZ)前三季度归母净亏损2404.89万元

Core Viewpoint - The company reported a revenue of 1.593 billion yuan for the first three quarters, reflecting a year-on-year increase of 7.71%, but also recorded a net loss attributable to shareholders of 24.0489 million yuan, with a basic loss per share of 0.0173 yuan [1] Financial Performance - Revenue for the first three quarters reached 1.593 billion yuan, which is a 7.71% increase compared to the previous year [1] - The net loss attributable to shareholders was 24.0489 million yuan [1] - Basic loss per share was reported at 0.0173 yuan [1]